• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Better together: antiobesity medications and bariatric surgery for the management of obesity.

作者信息

Pournaras Dimitri J, Lingvay Ildiko, Sumithran Priya

机构信息

Department of Bariatric and Metabolic Surgery, North Bristol NHS Trust, Bristol, UK.

Division of Endocrinology, Department of Internal Medicine and Peter O'Donnel Jr School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

出版信息

Br J Surg. 2024 Nov 27;111(12). doi: 10.1093/bjs/znae294.

DOI:10.1093/bjs/znae294
PMID:39612580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11606185/
Abstract
摘要

相似文献

1
Better together: antiobesity medications and bariatric surgery for the management of obesity.
Br J Surg. 2024 Nov 27;111(12). doi: 10.1093/bjs/znae294.
2
Addressing insurance-related barriers to novel antiobesity medications: Lessons to be learned from bariatric surgery.解决新型抗肥胖药物的保险相关障碍：从减肥手术中吸取的教训。
Obesity (Silver Spring). 2022 Dec;30(12):2338-2339. doi: 10.1002/oby.23556. Epub 2022 Oct 3.
3
Preoperative and early adjuvant weight loss medications in bariatric surgery patients with body mass index over 60 or suboptimal initial response to surgery.肥胖症手术患者体重指数超过 60 或手术初始反应不佳时的术前和早期辅助减肥药物。
Surg Obes Relat Dis. 2023 Aug;19(8):832-840. doi: 10.1016/j.soard.2023.01.021. Epub 2023 Feb 15.
4
Pharmacogenomics of Medication-Induced Weight Gain and Antiobesity Medications.药物引起的体重增加和减肥药的药物基因组学。
Obesity (Silver Spring). 2021 Feb;29(2):265-273. doi: 10.1002/oby.23068.
5
Antiobesity drugs before and after bariatric surgery - how to make the best use of them.减重手术前后的抗肥胖药物——如何最大限度地利用它们。
Cas Lek Cesk. 2022 Summer;161(3-4):107-113.
6
Obesity and Eligibility for Obesity Treatments Among Adults With Disabilities in the U.S.美国残疾成年人肥胖症及肥胖症治疗资格
Am J Prev Med. 2022 Oct;63(4):513-520. doi: 10.1016/j.amepre.2022.04.003. Epub 2022 May 23.
7
Assessment and medical management of weight regain after adolescent metabolic and bariatric surgery: a narrative review.青少年代谢和减重手术后体重反弹的评估与医学管理：一项叙述性综述
Surg Obes Relat Dis. 2025 Jan;21(1):24-32. doi: 10.1016/j.soard.2024.10.008. Epub 2024 Oct 12.
8
Obesity management before and after pancreas transplantation.胰腺移植前后的肥胖管理
Curr Opin Organ Transplant. 2025 May 5. doi: 10.1097/MOT.0000000000001226.
9
Precision medicine for obesity: current evidence and insights for personalization of obesity pharmacotherapy.肥胖症的精准医学：肥胖症药物治疗个性化的当前证据与见解
Int J Obes (Lond). 2025 Mar;49(3):452-463. doi: 10.1038/s41366-024-01599-z. Epub 2024 Aug 10.
10
Treatment with Antiobesity Drugs in Weight Regain After Bariatric Surgery: a Retrospective Cohort Study.减重手术后体重反弹时使用抗肥胖药物治疗：一项回顾性队列研究。
Obes Surg. 2023 Sep;33(9):2941-2944. doi: 10.1007/s11695-023-06736-7. Epub 2023 Jul 19.

本文引用的文献

1
Role of obesity-management medications before and after metabolic bariatric surgery: a systematic review.代谢性减重手术前后肥胖管理药物的作用：一项系统综述
Br J Surg. 2024 Nov 27;111(12). doi: 10.1093/bjs/znae284.
2
International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery: expert guideline by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).国际肥胖与代谢病外科联合会（IFSO）关于肥胖管理药物在代谢性减重手术中的作用的国际共识立场声明：专家指南
Br J Surg. 2024 Nov 27;111(12). doi: 10.1093/bjs/znae283.
3
Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation.将肥胖管理作为 2 型糖尿病的主要治疗目标：是时候重新调整对话了。
Lancet. 2022 Jan 22;399(10322):394-405. doi: 10.1016/S0140-6736(21)01919-X. Epub 2021 Sep 30.
4
Type 2 diabetes: multimodal treatment of a complex disease.2型糖尿病：一种复杂疾病的多模式治疗
Lancet. 2015 Sep 5;386(9997):936-7. doi: 10.1016/S0140-6736(15)00132-4.